Medication-related waste hits poorest states harder, ESI study finds
ORLANDO, Fla. — Unnecessary spending related to medications totaled nearly half a trillion dollars last year, and much of that was in the poorest states in the country, according to pharmacy benefit manager Express Scripts.
ESI said the country wasted $418 billion on bad medication-related decisions, including $55.8 billion spent on higher-priced medications when cheaper alternatives were available; and $269.4 billion went to expenses related to poor medication adherence.
On a state-by-state level, Mississippi, the poorest state in the country, had the most wasteful spending, totaling $1,622.76 per resident. Other poor states with a high degree of waste included Louisiana, Arkansas, Alabama, Kentucky, Tennessee, South Carolina, New Mexico and Oklahoma. States in the Midwest and Northeast had the lowest levels of avoidable costs, with Vermont having the lowest overall at $1,004.39 per person.
FDA approves second BD Rx generic injectable drug
FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a second product in BD’s new line of injectable drugs, the company said Tuesday.
BD Rx, the pharmaceutical arm of the medical technology manufacturer, whose name stands for Becton, Dickinson and Co., received FDA approval for metoclopramide, part of its BD Simplist line of ready-to-administer pre-filled generic injectables. The product is an antiemetic, a drug used to stop vomiting.
The company previously launched BD Simplist diphenhydramine hydrochloride injection, an antihistamine, last month. The company plans to launch 20 to 30 products in the line over the next few years.
"After a successful launch of BD Simplist pre-filled injectables, we’re excited to be coming out with a second drug that is commonly used by clinicians," BD Rx president Mark Sebree said. "This is just the beginning of our new line of pre-filled injectable products."
The company said that every injection carries the potential for medication error, but while traditional vial and syringe injections, clinicians perform up to 20 steps; with the BD Simplist syringes, the sequence is reduced to about 12 steps.
Warner Chilcott receives FDA approval for Minastrin 24 FE
DUBLIN — The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.
Warner Chilcott announced the approval of Minastrin 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) for prevention of pregnancy.
The drug maker said an unnamed third-party company would manufacture the drug, but it did not expect to launch it this year.